CP Q1 2026 Earnings EPS Misses Estimates Stock Slips OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short WIMI Q4 2020 Earnings EPS Misses Estimates Amidst Market Decline Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher XCUR Q2 2022 Earnings EPS Miss Widens as PreRevenue Biotech Shares Edge Higher HEPS Q1 2026 Earnings Negative EPS Weighs on Stock Amid Ongoing Operational Challenges